chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax 20DEC95&21DEC95 pt exp a fever >101;reported stated that fever lasted 25 days&was unrelated to the vax;No further details were provided;
Mom called concerned stating that patient received 2nd Covid vaccine this morning and is now having trouble breathing. Mom stated that patient was seen on 08/25/2022 for second Covid vaccine and was normal after vaccine that morning. Mom stated that she took patient to daycare afterwards and patient fell asleep on the care ride. Mom said that this was out of character for the patient especially since the patient slept all the way through the night. Mom stated that she dropped patient off at daycare and at 1400 mom received a call from the daycare. According to mom, the daycare told her that the patient was having abnormal breathing and told her to come pick patient up. Mom stated that patient breathing is abnormal but his face has not changed color. Triage nurse listened over the phone to the patient breathing and the patient was grunting with each breath for periods of time and then breathing normally. Mom stated that she believed patient respiration rate is high but every time she set him down to count it, he started crying. Mom denied patient having slow/shallow breathing, cyanosis, retractions, wheezing, or vomiting. Mom stated that patient activity level, eating, and drinking are decreased. Mom stated that she did not know if patient had been regularly urinating and when his last urination was because she had just picked patient up from daycare. Mom stated that patient eyes seemed to be glazed over as if he was taking medications and is more tired than normal. Mom was advised per provider to be seen in the emergency room for further and more immediate evaluation. Outcome is unknown as follow up has not been scheduled and patient was taken local Hospital.
Pt felt warm, hot , and dizzy 2 days after vaccine. This resolved spontaneously. He was given a dose of benadryl 25mg prophylactically.
Generalized erythema multiforme and generalized "targetoid plaques" in both lower and upper extremities. They start as small red lesions that progress to larger dark scaly lesions. These lesions are very itchy, red and swollen.
29 y/o F otherwise well noting no symptoms the morning of recieving her 1st dose Moderna COVID19 vaccination. 8 hours following the vaccination and exercising from the gym, patient noted headache, chills, a fever of 101.2F, and constipation. Patient did report mild improvement of symptoms after taking motrin and tylenol with slow improvement of symptoms though complaints 5 days later for increased swelling of ankles/feet/wrists/ankles bilaterally of unknown cause. No new dietary changes, foods consumed, medications, or history of similar issues in the past.
patient was "seeing stars" immediately after injection (told mom, not immunizer)--mom had her remain seated for ~5 min, then when she was feeling better she attempted to walk away and made it about 20 yards when she had episode of syncope. following fainting episode she came to be alert again in under a min; she heard pharmacist on duty direct technician to call 911. following episode, she remained seated at pharmacy for ~30 min, her blood pressure was low, and she was given water while seated. she had just eaten lunch prior to immunization, so unlikely due to low blood sugar.
he has perspiration so bad he has to change under clothes.; He feels lazy. He gets heat; he feels lazy; feeling cold; shake; I'm getting sweat every night.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administration date 02May2021 (Batch/Lot number: unknown) at the age of 72 years as 2nd dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for COVID-19 immunization. The following information was reported: HYPERHIDROSIS (non-serious), outcome "not recovered", described as "he has perspiration so bad he has to change under clothes."; HEAT EXHAUSTION (non-serious), outcome "not recovered", described as "He feels lazy. He gets heat"; LAZINESS (non-serious), outcome "not recovered", described as "he feels lazy"; FEELING COLD (non-serious), outcome "not recovered", described as "feeling cold"; TREMOR (non-serious), outcome "not recovered", described as "shake"; HYPERHIDROSIS (non-serious), outcome "not recovered", described as "I'm getting sweat every night.". The events "he has perspiration so bad he has to change under clothes.", "he feels lazy. he gets heat", "he feels lazy", "feeling cold", "shake" and "i'm getting sweat every night." were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hyperhidrosis, heat exhaustion, laziness, feeling cold, tremor, hyperhidrosis. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information:  He is calling about the second Covid 19 vaccine he received on 02May2021. It is still sometimes affecting him badly. The first Covid 19 vaccine was ok. The second Covid 19 vaccine is a problem for him. He's having perspiration every night since he received the vaccine, 17 days ago. Then he feels lazy. He gets hot when he's doing something faster and if he stops the hotness goes away. One thing, he doesn't shake or feel cold anymore. He was waking up at 3:00AM or 4:00AM feeling cold. But the perspiration he had twice yesterday, once at 12:00AM and once at 2:00AM, he had to change his underwear twice.
Information has been received from a medical assistant concerning an 80 year old patient who in May or June 2007, was vaccinated with a second 0.5ml dose of PNEUMOVAX (Lot # 655766/0038U).  In May or June 2007, the patient experienced severe pain at the injection site and swelling.  Unspecified medical attention was sought.  At the time of this report, the patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
Client reports rash redness and pain to the injection site and up her shoulder and neck and went to Dr where she was treated with medications.
small knot at the vaccination site; but was still sore; This spontaneous report was received from a  female pharmacist of unknown age via a company representative refers to herself. There was no information about the patient's concurrent conditions, medical history, drug reactions, allergies or concomitant medication.       On 07-OCT-2019, the patient was vaccinated with the first dose hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # R029117 and expiration date 10-JUL-2021) intramuscular to prevent human papilloma virus (strength were not reported).   On that day, after vaccination, the patient developed a small knot at the vaccination site (vaccination site nodule) and soreness (vaccination site pain). On 09-OCT-2019 (2 days after vaccination), the knot resolved but the site was still sore. The patient did not seek medical attention.   The causal relationship between the events and therapy with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not reported.
After my first second dose (this was the 3rd dose as a booster) I had the same effects. Bloated stomach upon waking, and heartburn after eating as well as while laying down to sleep. This lasted over 2 months after the second dose, and has now been lasting over a week since my booster shot.
Pain in left arm; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in left arm) and PYREXIA (Fever) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in left arm) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in left arm) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
One week after the first dose, 4/23, right before bed, I felt the left arm itching a little, approximately 10 pm.  During the night it was tender when I laid on it.  The next morning, 4/24, it was red and a little swollen and tender to the touch but it did not itch.  By the next day,4/25, the redness had improved and the swelling also.  By 4/26 there was only a little pink left, no itching or tenderness.
Patient was minor, age 17, at time of first Moderna dose on 3/25/21.  Received  COVID-19 vaccination with Moderna instead of Pfizer.  Moderna not authorized for use in patients less than 18 years of age.  Patient presented with her mother on 4/22/21 (28 days after 1st dose of Moderna)  for her scheduled 2nd dose of Moderna vaccine.  At patient check-in, it was discovered that patient had received the wrong vaccine for her first dose; all info was verified by 2 staff members.  Patient still age 17 at time of presentation for 2 dose of Moderna.  CDC guidelines for 'Recommendation for COVID-19 Vaccine Administration Errors and Deviations'  for 'Unauthorized age group' were consulted to determine how to proceed with 2nd dose.  Per guidelines, patient was administered a 2nd dose of Moderna as off-label use 'because Moderna vaccine is not authorized in patient's age group of 16-17 year olds.
A nurse reported that a 24 month old child received an injection of Acel-Immune on 5/22/00. The child was receiving Amoxicillin for the treatment of bronchitis at the time of immunization. On 5/24/2000, the child developed an injection site reaction characterized by redness and swelling at the site of Acel-Immune administration. The reaction was treated with Diphenhydramine and the child recovered. This is 1 out of 4 patients from this facility who had an adverse experience following receipt of Acel-Immune lot 469-396 or the concomitantly administered vaccines.
body aches to "back, legs, knees and ankles," loss of appetite, fatigue and mild cough. Hypoxia  Pneumonia due to COVID-19 virus  Nausea & vomiting  COVID-19 virus infection
08/28/21 Height 6ft 3 in weight 107kg 56yo M transferred to Hospital for Cath Lab procedure from another Hospital -Posterior STEMI alert.  Patient stated to have no medical history or on any medications. He reported receiving both Pfizer vaccines (second dose mid to end of July). Patient started feeling ill on 08/25/21 chest pressure, flu like symptoms. Rapid flu /covid test negative. VSS. At arrival to ED patient had elevated troponin at 29.88, WBC 17.43 CRP 207.4 EKG +STEMI, afebrile on ra o2 98% and BP and HR normal limits . PCR covid pending. Patient's symptoms prior to Cath Lab was chest pressure with inspiration 5/10. He received Heparin 4000Units, Morphine 2 mg and ASA 324mg.  Cath Lab results showed 60%mid vessel lesion, 98% lesion in mid vessel cannot r/o bridging collaterals, Mid LCxs most likely the culprit.
p/vax pt devel cellulitis, h/a, eye pain;required oral ATB, pain & eye med;
PERSON RECEIVED A MODERNA VACCINE ON 2-27-21 AND PFIZER ON 4-3-21
This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with the first dose VARIVAX, dose route and frequency unknown. On 31-MAY-2007 the patient was vaccinated with improperly stored VARIVAX lot # 656078/0169U dose number 2. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Pain aggravated in both instances; This is a spontaneous report from a contactable consumer. This 50-year-old male consumer reported himself who received first and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via intramuscular route to left arm on Mar2021 at 13:00 and on 05Apr2021 at 13:00 as SINGLE dose for covid-19 immunization respectively and was administered at Health Clinic/Administration facility. Medical history included degenerated disc between L4/L5, episode of serious pain happened in mid-2016, post the treatment, he was ok and known allergies included IV dye and Ibuprofen. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included Amlodipine besylate 2.5mg, given for unknown indication and start date and stop date was not provided. The patient reported that post the vaccination in Mar2021 and then second dose in 05Apr2021, his pain aggravated in both instances, and he was not back to normal even as of 11Jun2021. He has been put on a regime of oral Prednisone for a week since 12Jun2021 and getting some relief in pain. Event resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the event was recovering.  The lot/batch number was not available despite the follow-up attempts made. Follow-up attempts completed. No further information was expected.
Heart rate increased within 5 minutes of having the shot, went from 72 to 114.   My heart rate stayed at 109 or more until 10 PM the next night when its slowly went down to a normal heart rate.  At 3 am  (12 hours after the shot) i had  a blinding debilitating headache that lasted until 9pm the next night.   It also affected my vision.   The headache was so bad i could not concentrate on the simplest task.  I  was unsure of what i could take for the headache.   So, I did not take anything.    When i woke up i was very tired and this lasted until the following day.  6am i had a fever of 102.3 this went down to 100.4 at 9:15 pm that night.  I also had chills for several hours. 9:20 AM  the nausea started followed by vomiting and dizziness.   This only lasted for a few hours.    I  experienced very vivid dreams the night of the shot.    I only drank some coconut water all day and could not eat any food.  The next day Saturday March 27 i felt better but the fatigue did not go away until late in the evening.   Sleeping seemed to help but i could only sleep for 2- 3 hours at the most.
This spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 20-FEB-2015, the patient was vaccinated with ZOSTAVAX for its intended purpose: the prevention of shingles (lot number, dosage and route of administration not provided). As a direct result of ZOSTAVAX, the patient suffered from a shingles outbreak, in addition to chronic pain, rash and lesions to various parts of the body. The pt did not have a shingles outbreak until 11-SEP-2017. As a direct result of the ZOSTAVAX, the pt suffered mental and emotional distress due to resulting physical limitations and the seriousness of her condition. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of the event was considered to be not recovered. Shingles outbreak was considered to be disabling. Additional information has been requested.
Initial and follow-up information has been received from a physician concerning a 16 month old female who on 05-MAY-2004 was vaccinated with a first dose of MMR II (lot number not known). On 23-JUN-2004 the patient experienced febrile seizure seven weeks after the vaccine was administered. She was not a patient of the physician at the time; however there was fear of febrile seizure with the second dose. There was no product quality complaint. The febrile seizure was considered to be an other important medical event. Additional information has been requested. Follow-up information from the physician indicated that the febrile seizure was not related to MMR II. Upon internal review, febrile seizure was considered to be an other important medical event. Additional information is not available.
Patient received an adult 12+ years dose of Pfizer COVID-19 vaccine instead of the authorized 5-11 yrs dose of Pfizer COVID-19 vaccine.   Parents notified via letter on 3/23/2023.
Large welts all over his body, temperature of 100.1F, eyes swollen together, blood vessels popped and caused bruising. States he had some swelling X 2 weeks. Medication was given. Mom does not know what was given.
Vaccine administration error. No adverse reactions reported for this patient. The Pfizer pediatric orange cap vial (ages 5 to 11) administered (undiluted). The vaccine should have been diluted with 1.3mL sterile 0.9% sodium chloride. The amount of vaccine administered: 0.2mL of undiluted serum, resulting in a dose 3 times more concentrated than the advised dose. This patient was 1 of 7 individuals to have received improperly diluted vaccine. Only one staff member was responsible for the errors, but all staff retrained on storage, dilution and administration of the vaccine. Chart audits performed to identify affected patients.
7 days after receiving the vaccine -  round red, swollen, itchy, hard  at injection site
High fever, chills, severe body aches. Loss of appetite, nausea and diarrhea
This spontaneous report as received from a nurse practitioner (also reported as nurse prescribed) refers to a 17 years old female patient of unknown age. the patient's pertinent medical history, current conditions and concomitant medications were not reported. On 09-JUL-2016, the patient was vaccinated with GARDASIL 9, (lot/batch # K014891, expiry date: 10-MAY-2017) intramuscularly, which was later found to have possibly undergone a temperature excursion due to a broken data logger. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
This spontaneous report was received from a Registered nurse regarding a 15 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 05-JUL-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis. No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports received from the same reporter.  Sender's Comments: US-009507513-1804USA005153.
A small rash has formed on my neck that is somewhat painful, incredibly dry rash; very red, rash; This is a spontaneous report received from a contactable consumer, the patient. A 23-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6203) via an unspecified route of administration in the left arm on 17Mar2021 at 11:00 (at the age of 23-years-old) for COVID-19 immunisation. Medical history included obesity. The patient received birth control, iron multivitamin (MANUFACTURER UNKNOWN) within 2 weeks of vaccination. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 17Mar2021, the patient experienced small rash formed on his neck that is somewhat painful, very red, and became incredibly dry. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of painful dry rash neck and red rash was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Presented at 32 weeks of pregnancy complaining of leg swelling for 'the past couple weeks' with acute worsening since the day before presentation.  Received the COVID-19 vaccines at 19 weeks and 23 weeks.  Received the Tdap vaccine at 27 weeks.  She presented to the hospital at 32 weeks with a complaint of leg swelling.  She had severe range new-onset hypertension/preeclampsia. She was recommended for induction of preterm labor due to the development of pulmonary edema and ultimately required a cesarean delivery at 32 weeks.
Bilateral pulmonary embolism, clot in leg, pneumonia developed after the vaccine. Patient was hospitalized for 3 nights.
Upon arrival for her second dose in the Moderna COVID vaccine series, the patient explained to the pharmacy staff that a day after receiving her first dose she experienced some difficulty breathing, nausea, and vomiting.  These symptoms prompted her to call in sick from work and return home.  The patient claimed that she only treated herself by drinking water.  By the next day (June 30th), she was feeling back to full health.
Burning with fever, shivering, 101 degree fever, lyphnodes in arm, size of small mushroom, very uncomfortable , stiff arm, lypnodes in neck swollen, stiff neck, extremely pain, painful back (feels like sunburn), couldn't eat or  drink for 3 days, threw up water. Symptoms lasted for 3 days. Back pain, swollen lympnodes, stiff arm  and neck still ongoing. Doctor made a house call, prescribed tylonol and ibopropin.  Ongoing fatique.
patient got up in the early morning hours of 6/11/22 to go to the bathroom.  as he was walking to bathroom, he felt dizzy and started losing his balance and found it difficult to hold himself up.  sought a safe landing and did fall.  sat still for a few moments and patient returned to bed.   awoke in morning around 8 am feeling better.  patient states that on Friday, 6/10/22 he was experiencing a headache and took Tylenol before going to bed.
pt recvd vax & 12 hrs post vax devel t105.6 R w/shivering, listlessness;
Has gotten hot, nauseous and then blacked out and throws up, this has happened now 4 times.
4/23/23 I had a very bad sore throat , aches, pains, chills and heavy chest and nasal congestion. I took an at home COVID test and it was negative. 4/25/23 I still tested negative, and symptoms were continuing. I went to the clinic and had a positive PCR COVID test. I did an at home COVID test on 4/30/23 and it was positive.  This morning, I took an At Home COVID test and it was negative.  I still have some of the symptoms, but they are better.
Pt vaccinated with DTP developed fever of 104 plus generalized seizure 14 hrs following DTP #3.
18 hours after vaccine injection I started getting chills, fatigue, and back pain. This lasted for 2 full days. Then on 2/03/2021 I started getting a head pain in the back of my head. Then on 02/04/2021 I woke up with neck and shoulder pain. Current for 8 days now. Not better. Cant turn my head or shoulders. Same side as injection sight.
series of 4 periods where I became quite hot inside and broke out in a heavy dripping sweat over a period of 6 hours or so. It would happen each time, lasting only 15 minutes or so.